Cargando…

Body composition measurements and risk of hematological malignancies: A population-based cohort study during 20 years of follow-up

High body mass index (BMI) is associated with development of hematological malignancies (HMs). However, although BMI is a well-established measurement of excess weight, it does not fully reflect body composition and can sometimes misclassify individuals. This study aimed at investigating what body c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hagström, Hannes, Andreasson, Anna, Carlsson, Axel C., Jerkeman, Mats, Carlsten, Mattias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6107196/ https://www.ncbi.nlm.nih.gov/pubmed/30138405 http://dx.doi.org/10.1371/journal.pone.0202651

Ejemplares similares

Effect of common genetic variants on the risk of cirrhosis in non‐alcoholic fatty liver disease during 20 years of follow‐up
por: Holmer, Magnus, et al.
Publicado: (2022)

Long-term follow up of patients with hematological malignancies treated with total body irradiation using intensity modulated radiation therapy
por: Ladbury, Colton, et al.
Publicado: (2022)

Risk of fractures and subsequent mortality in non‐alcoholic fatty liver disease: A nationwide population‐based cohort study
por: Wester, Axel, et al.
Publicado: (2022)

Improved prediction of 10‐year risk of severe liver disease in the general population using commonly available biomarkers
por: Hagström, Hannes, et al.
Publicado: (2022)

Risk for development of severe liver disease in lean patients with nonalcoholic fatty liver disease: A long‐term follow‐up study
por: Hagström, Hannes, et al.
Publicado: (2017)

Expanded clinical and experimental use of SOX11 - using a monoclonal antibody
por: Nordström, Lena, et al.
Publicado: (2012)

Randomised prostate cancer screening trial: 20 year follow-up
por: Sandblom, Gabriel, et al.
Publicado: (2011)

Risk Behaviors Associated with Alcohol Consumption Predict Future Severe Liver Disease
por: Hagström, Hannes, et al.
Publicado: (2019)

Physical activity and body composition outcomes of the GreatFun2Run intervention at 20 month follow-up
por: Gorely, Trish, et al.
Publicado: (2011)

Natural Killer Cells in Myeloid Malignancies: Immune Surveillance, NK Cell Dysfunction, and Pharmacological Opportunities to Bolster the Endogenous NK Cells
por: Carlsten, Mattias, et al.
Publicado: (2019)

Sars-CoV2 Antibody Responses in Patients with Hematological Malignancies Following Anti-CD20 Therapy
por: Guerra, Veronica A, et al.
Publicado: (2021)

Whole-Body Electromyostimulation Combined With Individualized Nutritional Support Improves Body Composition in Patients With Hematological Malignancies – A Pilot Study
por: Schink, Kristin, et al.
Publicado: (2018)

Hematologic Malignancies: ASCO20 Virtual Scientific Program Highlights for the Advanced Practitioner
Publicado: (2020)

Pharmacologically relevant doses of valproate upregulate CD20 expression in three diffuse large B-cell lymphoma patients in vivo
por: Damm, Jesper Kofoed, et al.
Publicado: (2015)

Time trends in mortality and life expectancy in 22,658 patients hospitalized with alcohol-associated cirrhosis: A nationwide cohort study
por: Wester, Axel, et al.
Publicado: (2023)

Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience
por: Salles, Gilles, et al.
Publicado: (2017)

CDC20 in and out of mitosis: a prognostic factor and therapeutic target in hematological malignancies
por: Bruno, Samantha, et al.
Publicado: (2022)

Accuracy of Recalled Body Weight – A Study with 20-years of Follow-up
por: Dahl, Anna K, et al.
Publicado: (2013)

Russell Body Esophagitis: A Possible Indication to Screen for Hematologic Malignancy
por: Garcia, Glenn E, et al.
Publicado: (2022)

Bacterial Infections Following Splenectomy for Malignant and Nonmalignant Hematologic Diseases
por: Leone, Giuseppe, et al.
Publicado: (2015)

Hematologic malignancies following immune checkpoint inhibition for solid tumors
por: van Eijs, Mick J. M., et al.
Publicado: (2022)

Carbamazepine and Hematological Malignancies
por: Yavaşoğlu, İrfan, et al.
Publicado: (2013)

Malignant benign hematology
por: Sholzberg, Michelle
Publicado: (2018)

Neoantigens in Hematologic Malignancies
por: Biernacki, Melinda A., et al.
Publicado: (2020)

Deubiquitinases in hematological malignancies
por: Lei, Hu, et al.
Publicado: (2021)

Autophagy in Hematological Malignancies
por: García Ruiz, Olga, et al.
Publicado: (2022)

Functional and quantitative evaluation of the 20S proteasome in serum and intracellular in145 moroccan patients with hematologic malignancies
por: Filali, Hassan, et al.
Publicado: (2022)

Risk of injuries before and after a diagnosis of cirrhosis: A population-based cohort study
por: Shang, Ying, et al.
Publicado: (2023)

Complete Reduction of Leg Lymphedema in 126 Patients with Liposuction without Recurrence - 20 Years’ Follow-up
por: Brorson, Hakan, et al.
Publicado: (2022)

Evaluation of nine formulas for estimating the body surface area of children with hematological malignancies
por: Wu, Qing, et al.
Publicado: (2022)

Clonal Hematopoiesis: Role in Hematologic and Non-Hematologic Malignancies
por: Testa, Ugo, et al.
Publicado: (2022)

Molecular Aspects of Hematological Malignancies and Benign Hematological Disorders
por: Găman, Amelia Maria
Publicado: (2023)

Australian Aboriginal Birth Cohort study: follow-up processes at 20 years
por: Sayers, Susan, et al.
Publicado: (2009)

Immune-based Therapies for Hematological Malignancies: An Update by the EHA SWG on Immunotherapy of Hematological Malignancies
por: Einsele, Hermann, et al.
Publicado: (2020)

Development of Serum Marker Models to Increase Diagnostic Accuracy of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: The New LINKI Algorithm Compared with Established Algorithms
por: Lykiardopoulos, Byron, et al.
Publicado: (2016)

Allergic conditions and risk of hematological malignancies in adults: a cohort study
por: Söderberg, Karin C, et al.
Publicado: (2004)

1119 Respiratory Viral Infections in a Cohort of Patients with Hematological Malignancies
por: Vilar-Compte, Diana, et al.
Publicado: (2014)

Risk of hematological malignancy in blood donors: A nationwide cohort study
por: Zhao, Jingcheng, et al.
Publicado: (2020)

Outcomes in Patients with Hematological Malignancies Receiving Anti-CD20 Therapy in the Setting of COVID-19 Infection
por: Lopez, Carlos A, et al.
Publicado: (2020)

Oncolytic Virotherapy for Hematological Malignancies
por: Bais, Swarna, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_cul9dj9pjefaai5gn4muk4m3d4